Feb 21
GATC’s use of next generation sequencing dramatically cuts costs
BioIT-World recently ran an article on GATC Biotech, a German sequencing provider that is the first commercial outfit in the world to offer all three next generation sequencing platforms (454,SOLID, Solexa).
In the article, CEO Peter Pohl made this interesting remark regarding the impact that NGS is having on the price of commercial sequencing services:
Back in 1990, Pohl says cost of sequencing a base pair was $25. “Today, the cost per base pair is definitely less than 0.1 cent/base pair. This is 30,000 times less than just 16 years ago! If we look forward another 16 years, we come to a price for onefold coverage of a human genome of [about $99].